FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Hedner

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Concepts & Ideas

Co-author Network

Publications

TOP 3
Thomas Hedner; Krzysztof Narkiewicz; Suzanne Oparil; Sverre E Kjeldsen
Primary cardiovascular prevention by Mediterranean diet - The PREDIMED trial.
Thomas Hedner; Olle Larkö
[Swedish research needs Swedish innovation. The research and innovation strategy must strengthen Swedish competitiveness].
Erik Larsson; Bo Hedblad; Thomas Hedner; Sverre E Kjeldsen; Olle Melander; Björn Wahlstrand; Per Lindahl
Hypertension and genetic variation in endothelial-specific genes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Hedner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Thomas Hedner; Krzysztof Narkiewicz; Suzanne Oparil; Sverre E Kjeldsen
Primary cardiovascular prevention by Mediterranean diet - The PREDIMED trial.
Blood pressure 2013;22(3):129-30.
2013: Thomas Hedner; Olle Larkö
[Swedish research needs Swedish innovation. The research and innovation strategy must strengthen Swedish competitiveness].
Läkartidningen 2013;110(5):204-5.
2013: Erik Larsson; Bo Hedblad; Thomas Hedner; Sverre E Kjeldsen; Olle Melander; Björn Wahlstrand; Per Lindahl
Hypertension and genetic variation in endothelial-specific genes.
PloS one 2013;8(4):e62035.
2012: Thomas Hedner; Lars Gatenbeck
[Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
Läkartidningen 2012;109(26-28):1280-1.
2012: Thomas Hedner; Ivor Cowlrick; Boo Edgar; Lars Lind; Michael Olausson; Tobias Thornblad; Magnus Klofsten
[Major changes in the global pharmaceutical industry].
Läkartidningen 2012;109(7):324-5.
2011: Thomas Hedner; Krzysztof Narkiewicz; Sverre Kjeldsen; Suzanne Oparil
Antihypertensive therapy and cancer risks?
Blood pressure 2011;20(3):127-8.
2010: Thomas Hedner; Suzanne Oparil; Krzysztof Narkiewicz; Ingrid Os
Cardiovascular risks in HIV patients.
Blood pressure 2010;19(6):325-7.
2009: Björn Wahlstrand; Marju Orho-Melander; Lotta Delling; Sverre Kjeldsen; Krzysztof Narkiewicz; Peter Almgren; Thomas Hedner; Olle Melander
The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension.
Journal of hypertension 2009;27(4):769-73.
2008: Patrik Färbom; Björn Wahlstrand; Peter Almgren; Stanko Skrtic; Jan Lanke; Lars Weiss; Sverre Kjeldsen; Thomas Hedner; Olle Melander
Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension: the nordic diltiazem study.
Hypertension 2008;52(1):115-22.
2008: Thomas Hedner; Suzanne Oparil; Krzysztof Narkiewicz; Sverre E Kjeldsen
Achieving better blood pressure control.
Blood pressure. Supplement 2008;1():3-4.
2008: Anna Benrick; Pernilla Jirholt; Ingrid Wernstedt; Maria Gustafsson; Jürgen Scheller; Anna-Lena Eriksson; Jan Borén; Thomas Hedner; Claes Ohlsson; Torleif Härd; Stefan Rose-John; John-Olov Jansson
A non-conservative polymorphism in the IL-6 signal transducer (IL6ST)/gp130 is associated with myocardial infarction in a hypertensive population.
Regulatory peptides 2008;146(1-3):189-96.
2008: Thomas Hedner; Sverre Kjeldsen; Susanne Oparil; Krzysztof Narkiewics
Management of older hypertensive patients.
Blood pressure 2008;17(4):184-5.
2008: Sverre E Kjeldsen; Thomas Hedner; Krzystof Narkiewicz; Suzanne Oparil
More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension.
Blood pressure 2008;17(3):132-3.
2008: Sverre E Kjeldsen; Suzanne Oparil; Krzysztof Narkiewicz; Thomas Hedner
A stunning day in hypertension research - Results of ONTARGET, ACCOMPLISH and HYVET.
Blood pressure 2008;17(2):68-9.
2008: Thomas Hedner; Sverre E Kjeldsen; Krzysztof Narkiewicz; Suzanne Oparil
Urgent need to address quality control issues of out-of-office blood pressure measurement and patient risk assessment.
Blood pressure 2008;17(1):5-6.
2007: Thomas Hedner; Krzysztof Narkiewicz; Sverre E Kjeldsen
The evolution of ACE inhibition--a turning point in cardiovascular medicine.
Blood pressure. Supplement 2007;2():5-6.
2006: Parviz Yazdanparast; Bo Carlsson; Xing-Ying Sun; Xiao-He Zhao; Thomas Hedner; Jan Faergemann
Action of topical thyroid hormone analogues on glucocorticoid-induced skin atrophy in mice.
Thyroid : official journal of the American Thyroid Association 2006;16(3):273-80.
2006: Stanko Skrtic; Anders Niklason; T Leoo; Thomas Hedner
Risk factor identification and assessment in hypertension and diabetes (RIAHD) study.
Blood pressure 2006;15(6):367-74.
2006: Erland Linjer; Jan Jörnmark; Thomas Hedner; Bengt Jönsson
Predictors for high costs of hospital care in elderly hypertensive patients.
Blood pressure 2006;15(4):245-50.
2006: Hans Bokström; Rose-Marie Holst; Ola Hafström; Birgitta Swolin; Marie-Louise Johansson; Gertrud Brunlöf; Thomas Hedner
Fetal hemolytic anemia associated with maternal sulfasalazine therapy during pregnancy.
Acta obstetricia et gynecologica Scandinavica 2006;85(1):118-21.
2005: Jan Faergemann; Björn Wahlstrand; Thomas Hedner; Jörgen Johnsson; Reinhard H H Neubert; Lena Nyström; Howard Maibach
Pentane-1,5-diol as a percutaneous absorption enhancer.
Archives of dermatological research 2005;297(6):261-5.
2005: Sven Wallerstedt; Anna-Lena Eriksson; Claes Ohlsson; Thomas Hedner
Haplotype association analysis of the polymorphisms Arg16Gly and Gln27Glu of the adrenergic beta2 receptor in a Swedish hypertensive population.
Journal of human hypertension 2005;19(9):705-8.
2005: Jan Faergemann; Thomas Hedner; Peter Larsson
The in vitro activity of pentane-1,5-diol against aerobic bacteria. A new antimicrobial agent for topical usage?
Acta dermato-venereologica 2005;85(3):203-5.
2005: Erland Linjer; Thomas Hedner; Bengt Jönsson; Tord Ekbom; Lars H Lindholm; Björn Dahlöf; Ulf de Faire; Bengt Scherstén
Cost analysis of different pharmacological treatment strategies in elderly hypertensives.
Blood pressure 2005;14(2):107-13.
2004: Ingrid Wernstedt; Anna-Lena Eriksson; Anna Berndtsson; J Hoffstedt; Stanko Skrtic; Thomas Hedner; Lillemor Mattsson Hultén; Olov Wiklund; Claes Ohlsson; John-Olov Jansson
A common polymorphism in the interleukin-6 gene promoter is associated with overweight.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2004;28(10):1272-9.
2004: Sven Wallerstedt; Stanko Skrtic; Anna-Lena Eriksson; Claes Ohlsson; Thomas Hedner
Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive population.
Journal of hypertension 2004;22(7):1277-81.
2004: Anders Niklason; Thomas Hedner; Leo Niskanen; Jan Lanke
Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP).
Journal of hypertension 2004;22(3):645-52.
2004: Anna-Lena Eriksson; Stanko Skrtic; Anders Niklason; Lillemor Mattsson Hultén; Olov Wiklund; Thomas Hedner; Claes Ohlsson
Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population.
European heart journal 2004;25(5):386-91.
2004: Sverre E Kjeldsen; Ingrid Os; Thomas Hedner; Anders Himmelmann
Renal hypertensive target organ damage--new evidence emerges in diabetics and smokers.
Blood pressure 2004;13(6):324-5.
2004: Sven Wallerstedt; Anna-Lena Eriksson; Anders Niklason; Claes Ohlsson; Thomas Hedner
Serum leptin and myocardial infarction in hypertension.
Blood pressure 2004;13(4):243-6.
2004: Thomas Hedner; Sverre E Kjeldsen; Anders Himmelmann
Valuable lessons from VALUE.
Blood pressure 2004;13(4):196-7.
2004: Thomas Hedner; Anders Himmelmann
Cardiovascular complications of COX2 selective inhibitors cause considerable concern.
Blood pressure 2004;13(5):260-1.
2004: Thomas Hedner; Ola Samulesson; Peter Währborg; Hans Wadenvik; Kjell-Arne Ung; Anders Ekbom
Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.
Drugs 2004;64(20):2315-43; discussion 2344-5.
2004: Tord Ekbom; Erland Linjer; Thomas Hedner; Jan Lanke; Ulf de Faire; PO Wester; Björn Dahlöf; Bengt Scherstén
Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Blood pressure 2004;13(3):137-41.
2004: Anders Himmelmann; Sverre Kjeldsen; Thomas Hedner
Cardiovascular risk stratification: an important tool for treatment to lower cardiovascular disease risk.
Blood pressure 2004;13(3):125-6.
2004: Sverre E Kieldsen; Thomas Hedner; Anders Himmelmann
Prevention of cardiovascular disease in uncomplicated, mild hypertension--need for prospective data from intervention trials.
Blood pressure 2004;13(1):5-6.
2003: Peter Nilsson; Thomas Hedner; Anders Himmelmann; Thomas Kahan; Karin Manhem; Inger Norrvinsdotter-Borg; Fredrik Nyström; Per Svensson; Thomas Wallén
[The Swedish Society of Hypertension: cooperation with industry is desirable and necessary--with integrity preserved].
Läkartidningen 2003;100(21):1919-20.
2003: Thomas Hedner; Anders Himmelmann; Sverre E Kjeldsen
Masked hypertension--a new entity and challenge for clinical hypertension research and management.
Blood pressure 2003;12(5-6):261-3.
2003: Anders Himmelmann; Sverre E Kjeldsen; Thomas Hedner
Recent hypertension guidelines: JNC-7 and 2003 ESH/ESC.
Blood pressure 2003;12(4):196-7.
2003: Thomas Hedner; Anders Himmelmann; Sverre E Kjeldsen
Contrasting messages but not contradicting results from ALLHAT and ANBP2.
Blood pressure 2003;12(2):68-9.
2002: Thomas Hedner
The clinical profile of the angiotensin II receptor blocker eprosartan.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 2002;20(5):S33-8.
2002: Sverre E Kjeldsen; Thomas Hedner; Jan Otto Syvertsen; Per Lund-Johansen; Lennart Hansson; Jan Lanke; Lars H Lindholm; Ulf de Faire; Björn Dahlöf; Bengt E Karlberg
Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study.
Journal of hypertension 2002;20(6):1231-7.
2002: Sverre E Kjeldsen; Thomas Hedner; Jan Otto Syvertsen; Per Lund-Johansen; Lennart Hansson
Comparison of home and office blood pressure in treated hypertensives in the Nordic Diltiazem (NORDIL) Study.
Blood pressure 2002;11(6):371-6.
2002: Anders Himmelmann; Lennart Hansson; Thomas Hedner
Blood pressure measurement: a century of achievements and improvements in the year 2002.
Blood pressure 2002;11(6):325-7.
2002: Thomas Hedner; Anders Himmelmann; Lennart Hansson
Homocysteine and ADMA--emerging risk factors for cardiovascular disease?
Blood pressure 2002;11(4):197-200.
2002: Lennart Hansson; Thomas Hedner; Anders Himmelmann
Researchers receive record compensation from TV company for media insult linked to the calcium antagonist controversy.
Blood pressure 2002;11(3):132-3.
2002: Anders Himmelmann; Lannart Hansson; Thomas Hedner
The price you pay for hypertension management: incorporation of economic factors into clinical decision making.
Blood pressure 2002;11(1):4-5.
2001: Leo Niskanen; Thomas Hedner; Lennart Hansson; Jan Lanke; Anders Niklason
Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project.
Diabetes care 2001;24(12):2091-6.
2001: Lars H Lindholm; H Anderson; Tord Ekbom; Lennart Hansson; Jan Lanke; Björn Dahlöf; Ulf de Faire; K Forsén; Thomas Hedner; Erland Linjer; Bengt Scherstén; PO Wester; Torgil R Möller
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with Hypertension 2: a 5-year, prospective, randomised, controlled trial.
Lancet 2001;358(9281):539-44.
2001: Andreas Bergdahl; Stig Valdemarsson; Mikael Adner; XY Sun; Thomas Hedner; Lars Edvinsson
Enhanced endothelin-1-induced contractions in mesenteric arteries from rats with congestive heart failure: role of ET(B) receptors.
European journal of heart failure 2001;3(3):293-9.
2001: Sverre E Kjeldsen; Stevo Julius; Thomas Hedner; Lennart Hansson
Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials.
Blood pressure 2001;10(4):190-2.
2001: Anders Himmelmann; S Keinänen-Kiukaanniemi; A Wester; J Redón; R Asmar; Thomas Hedner
The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension.
Blood pressure 2001;10(1):43-51.
2001: Andreas Bergdahl; Stig Valdemarsson; XY Sun; Thomas Hedner; Lars Edvinsson
Enhanced Ca2+-induced contractions and attenuated alpha-adrenoceptor responses in resistance arteries from rats with congestive heart failure.
European journal of heart failure 2001;3(1):7-13.
2000: Lars H Lindholm; Lennart Hansson; Tord Ekbom; Björn Dahlöf; Jan Lanke; Erland Linjer; Bengt Scherstén; PO Wester; Thomas Hedner; Ulf de Faire
Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: results from the Swedish Trial in Old Patients with Hypertension-2. STOP Hypertension-2 Study Group.
Journal of hypertension 2000;18(11):1671-5.
2000: Lennart Hansson; Thomas Hedner; Per Lund-Johansen; Sverre E Kjeldsen; Lars H Lindholm; Jan Otto Syvertsen; Jan Lanke; Ulf de Faire; Björn Dahlöf; Bengt E Karlberg
Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
Lancet 2000;356(9227):359-65.
2000: B Everts; Peter Währborg; Thomas Hedner
COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs.
Clinical rheumatology 2000;19(5):331-43.
2000: Thomas Hedner
The problem of hypertension in the elderly.
Blood pressure. Supplement 2000;2():4-6.
2000: XH Zhao; XY Sun; D Erlinge; Lars Edvinsson; Thomas Hedner
Downregulation of adenosine and P2X receptor-mediated cardiovascular responses in heart failure rats.
Blood pressure 2000;9(2-3):152-61.
1999: Lennart Hansson; Lars H Lindholm; Tord Ekbom; Björn Dahlöf; Jan Lanke; Bengt Scherstén; PO Wester; Thomas Hedner; Ulf de Faire
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.
Lancet 1999;354(9192):1751-6.
1999: XH Zhao; XY Sun; Andreas Bergdahl; Lars Edvinsson; Thomas Hedner
Renal and cardiovascular role of the neuropeptide Y Y1 receptor in ischaemic heart failure rats.
The Journal of pharmacy and pharmacology 1999;51(11):1257-65.
1999: Malin Malmsjö; Andreas Bergdahl; Sebastian Möller; XH Zhao; XY Sun; Thomas Hedner; Lars Edvinsson; David Erlinge
Congestive heart failure induces downregulation of P2X1-receptors in resistance arteries.
Cardiovascular research 1999;43(1):219-27.
1999: Malin Malmsjö; Andreas Bergdahl; XH Zhao; XY Sun; Thomas Hedner; Lars Edvinsson; David Erlinge
Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure.
Cardiovascular research 1999;43(1):200-9.
1999: Thomas Hedner
Management of hypertension: the advent of a new angiotensin II receptor antagonist.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1999;17(2):S21-5.
1999: Lennart Hansson; Lars H Lindholm; Leo Niskanen; Jan Lanke; Thomas Hedner; Anders Niklason; K Luomanmäki; Björn Dahlöf; Ulf de Faire; C Mörlin; Bengt E Karlberg; PO Wester; J E Björck
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.
Lancet 1999;353(9153):611-6.
1999: B Everts; Björn Karlson; NJ Abdon; Johan Herlitz; Thomas Hedner
A comparison of metoprolol and morphine in the treatment of chest pain in patients with suspected acute myocardial infarction--the MEMO study.
Journal of internal medicine 1999;245(2):133-41.
1999: Thomas Hedner
Progress report on the Nordic diltiazem study (NORDIL): an outcome study in hypertensive patients.
Blood pressure 1999;8(5-6):296-9.
1999: B Everts; Björn Karlson; Peter Währborg; NJ Abdon; Johan Herlitz; Thomas Hedner
Pain recollection after chest pain of cardiac origin.
Cardiology 1999;92(2):115-20.
1999: Peter Währborg; Tore Eliasson; Nils Edvardsson; R Ekman; Clas Mannheimer; Thomas Hedner
Acute ischemic chest pain is not associated with increased calcitonin gene-related peptide (CGRP) levels in peripheral plasma nor in the coronary circulation.
Scandinavian cardiovascular journal : SCJ 1999;33(5):295-9.
1999: Mingyan Hou; Malin Malmsjö; Sebastian Möller; Emil Pantev; Andreas Bergdahl; XH Zhao; XY Sun; Thomas Hedner; Lars Edvinsson; David Erlinge
Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure.
Life sciences 1999;65(11):1195-206.
1999: Thomas Hedner; Anders Himmelmann
The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
Journal of hypertension 1999;17(1):129-36.
1999: Andreas Bergdahl; Stig Valdemarsson; T Nilsson; XY Sun; Thomas Hedner; Lars Edvinsson
Dilatory responses to acetylcholine, calcitonin gene-related peptide and substance P in the congestive heart failure rat.
Acta physiologica Scandinavica 1999;165(1):15-23.
1998: Björn Dahlöf; Richard B Devereux; Stevo Julius; Sverre E Kjeldsen; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Thomas Hedner; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.
Hypertension 1998;32(6):989-97.
1998: Andreas Bergdahl; T Nilsson; XY Sun; Thomas Hedner; Lars Edvinsson
Altered neuropeptide Y Y1 responses in mesenteric arteries in rats with congestive heart failure.
European journal of pharmacology 1998;360(2-3):165-73.
1998: A Pettersson; Thomas Hedner; Ian Milsom
Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia.
Acta obstetricia et gynecologica Scandinavica 1998;77(8):808-13.
1998: Ove K Andersson; Torbjörn Almgren; B Persson; Ola Samuelsson; Thomas Hedner; Lars Wilhelmsen
Survival in treated hypertension: follow up study after two decades.
BMJ (Clinical research ed.) 1998;317(7152):167-71.
1998: Anders Himmelmann; Thomas Hedner; L Hansson; C J O'Donnell; D Levy
Isolated systolic hypertension: an important cardiovascular risk factor.
Blood pressure 1998;7(4):197-207.
1998: O Samuelsson; K Pennert; Ove K Andersson; G Berglund; Thomas Hedner; B Persson; H Wedel; Lars Wilhelmsen
[Is antihypertensive treatment a risk factor of coronary disease? Therapy-related triglyceride increase nor diabetes increase the risk].
Läkartidningen 1998;95(11):1120-3.
1998: Tore Eliasson; Clas Mannheimer; F Waagstein; B Andersson; Claes-Håkan Bergh; LE Augustinsson; Thomas Hedner; G Larson
Myocardial turnover of endogenous opioids and calcitonin-gene-related peptide in the human heart and the effects of spinal cord stimulation on pacing-induced angina pectoris.
Cardiology 1998;89(3):170-7.
1998: Thomas Hedner; B Everts
The early clinical history of salicylates in rheumatology and pain.
Clinical rheumatology 1998;17(1):17-25.
1997: Lennart Hansson; Thomas Hedner; L Lindholm; Anders Niklason; K Luomanmäki; Leo Niskanen; Jan Lanke; Björn Dahlöf; Ulf de Faire; C Mörlin; Bengt E Karlberg; PO Wester; J E Björck
The Captopril Prevention Project (CAPPP) in hypertension--baseline data and current status.
Blood pressure 1997;6(6):365-7.
1997: Weiguo Zhang; X Sun; X Zhao; P Thorén; Thomas Hedner
Effects of calcium antagonist felodipine on renal sympathetic nerve activity in rats with congestive heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1997;11(5):645-50.
1997: Thomas Wallén; Sten Landahl; Thomas Hedner; Y Saito; I Masuda; K Nakao
Brain natriuretic peptide in an elderly population.
Journal of internal medicine 1997;242(4):307-11.
1997: Weiguo Zhang; X Sun; X Zhao; P Thorén; Thomas Hedner
Effects of hydralazine on renal sympathetic nerve activity in normal and congestive heart failure rats.
Acta physiologica Scandinavica 1997;161(1):7-14.
1997: Björn Dahlöf; R Devereux; Ulf de Faire; Frej Fyhrquist; Thomas Hedner; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
American journal of hypertension 1997;10(7 Pt 1):705-13.
1997: Thomas Wallén; Sten Landahl; Thomas Hedner; C Hall; Y Saito; K Nakao
Atrial natriuretic peptides predict mortality in the elderly.
Journal of internal medicine 1997;241(4):269-75.
1997: Thomas Wallén; Sten Landahl; Thomas Hedner; K Nakao; Y Saito
Brain natriuretic peptide predicts mortality in the elderly.
Heart (British Cardiac Society) 1997;77(3):264-7.
1997: Thomas Hedner; X Sun
Measures of endothelial function as an endpoint in hypertension?
Blood pressure. Supplement 1997;2():58-66.
1997: B Everts; Björn W Karlson; Johan Herlitz; NJ Abdon; Thomas Hedner
Effects and pharmacokinetics of high dose metoprolol on chest pain in patients with suspected or definite acute myocardial infarction.
European journal of clinical pharmacology 1997;53(1):23-31.
1997: Thomas Hedner; M Falk
Physician and patient evaluation of hypertension-related risks and benefits from treatment.
Blood pressure. Supplement 1997;1():26-34.
1997: Weiguo Zhang; A Pettersson; P Thorén; Thomas Hedner
Effects of 1,1-dimethylguanidine administration on blood pressure, heart rate and renal sympathetic nerve activity in normotensive and spontaneously hypertensive rats.
Acta physiologica Scandinavica 1997;159(1):1-6.
1997: XH Zhao; XY Sun; Lars Edvinsson; Thomas Hedner
Does the neuropeptide Y Y1 receptor contribute to blood pressure control in the spontaneously hypertensive rat?
Journal of hypertension 1997;15(1):19-27.
1996: T Wolff; H Samuelsson; Thomas Hedner
Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients.
Pain 1996;68(2-3):209-16.
1996: R Björkman; K M Hallman; Jan Hedner; Thomas Hedner; M Henning
Nonsteroidal antiinflammatory drug modulation of behavioral responses to intrathecal N-methyl-D-aspartate, but not to substance P and amino-methyl-isoxazole-propionic acid in the rat.
Journal of clinical pharmacology 1996;36(12 Suppl):20S-26S.
1996: Andreas Bergdahl; T Nilsson; L Cantera; L Nilsson; XY Sun; Thomas Hedner; David Erlinge; S Valdemarson; Lars Edvinsson
Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor.
European journal of pharmacology 1996;316(1):59-64.
1996: B Everts; B W Karlson; P Währborg; Thomas Hedner; Johan Herlitz
Localization of pain in suspected acute myocardial infarction in relation to final diagnosis, age and sex, and site and type of infarction.
Heart & lung : the journal of critical care 1996;25(6):430-7.
1996: Ola Samuelsson; K Pennert; O Andersson; G Berglund; Thomas Hedner; B Persson; H Wedel; Lars Wilhelmsen
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study.
BMJ (Clinical research ed.) 1996;313(7058):660-3.
1996: Q P Feng; XY Sun; Thomas Hedner
Cardiovascular responses and interactions by neuropeptide Y in rats with congestive heart failure.
Blood pressure 1996;5(5):312-8.
1996: I L Junggren; X Zhao; X Sun; Thomas Hedner
Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.
The Journal of pharmacy and pharmacology 1996;48(8):829-33.
1996: Z Chen; Jan Hedner; Thomas Hedner
Substance P-induced respiratory excitation is blunted by delta-receptor specific opioids in the rat medulla oblongata.
Acta physiologica Scandinavica 1996;157(2):165-73.
1996: T Nilsson; J You; X Sun; Thomas Hedner; Lars Edvinsson
Characterization of neuropeptide Y receptors mediating contraction, potentiation and inhibition of relaxation.
Blood pressure 1996;5(3):164-9.
1996: XY Sun; X H Zhao; David Erlinge; Lars Edvinsson; B Fallgren; Claes Wahlestedt; Thomas Hedner
Effects of phosphorothioated neuropeptide Y Y1-receptor antisense oligodeoxynucleotide in conscious rats and in human vessels.
British journal of pharmacology 1996;118(1):131-6.
1996: Q P Feng; Andreas Bergdahl; X R Lu; XY Sun; Lars Edvinsson; Thomas Hedner
Vascular alpha-2 adrenoceptor function is decreased in rats with congestive heart failure.
Cardiovascular research 1996;31(4):577-84.
1996: A Himmelmann; Thomas Hedner; E Snoeck; B Lundgren; Jan Hedner
Haemodynamic effects and pharmacokinetics of oral d- and l-nebivolol in hypertensive patients.
European journal of clinical pharmacology 1996;51(3-4):259-64.
1996: C Rangemark; H Lind; L Lindholm; Thomas Hedner; Ola Samuelsson
Lisinopril reduces postexercise albuminuria more effectively than atenolol in primary hypertension.
European journal of clinical pharmacology 1996;49(4):267-71.
1996: X Sun; J You; Thomas Hedner; David Erlinge; B Fellström; H Yoo; Claes Wahlestedt; Lars Edvinsson
alpha-Trinositol: a functional (non-receptor) neuropeptide Y antagonist in vasculature.
The Journal of pharmacy and pharmacology 1996;48(1):77-84.
1996: Henrik Scherstén; Thomas Hedner; Christopher G A McGregor; Virginia M Miller; G Mårtensson; Gerdt C Riise; F N Nilsson
Increased levels of endothelin-1 in bronchoalveolar lavage fluid of patients with lung allografts.
The Journal of thoracic and cardiovascular surgery 1996;111(1):253-8.
1995: A B Malmberg; B Fallgren; Thomas Hedner
Antinociceptive effect of alpha-trinositol, a novel D-myo-inositol phosphate derivative, in the formalin test in rats.
European journal of pharmacology 1995;294(2-3):609-15.
1995: T Wolff; H Samuelsson; Thomas Hedner
Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration.
Pain 1995;62(2):147-54.
1995: Andreas Bergdahl; Stig Valdemarsson; Emil Pantev; A Ottosson; Q P Feng; XY Sun; Thomas Hedner; Lars Edvinsson
Modulation of vascular contractile responses to alpha 1- and alpha 2-adrenergic and neuropeptide Y receptor stimulation in rats with ischaemic heart failure.
Acta physiologica Scandinavica 1995;154(4):429-37.
1995: Elinor Ben-Menachem; B Söderfelt; Anders Hamberger; Thomas Hedner; L I Persson
Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizures.
Epilepsy research 1995;21(3):231-6.
1995: XY Sun; Lars Edvinsson; H Yoo; Claes Wahlestedt; Thomas Hedner
Effects of some novel D-myo-inositol-phosphate derivatives on binding and sympathetic transmission.
Journal of cardiovascular pharmacology 1995;25(5):696-704.
1995: Elinor Ben-Menachem; Anders Hamberger; Thomas Hedner; E J Hammond; Basim M Uthman; J Slater; T Treig; H Stefan; R Eugene Ramsay; J F Wernicke
Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures.
Epilepsy research 1995;20(3):221-7.
1995: XY Sun; Q P Feng; X Zhao; Lars Edvinsson; Thomas Hedner
Cardiovascular and renal effects of alpha-trinositol in ischemic heart failure rats.
Life sciences 1995;57(12):1197-211.
1994: X Sun; Lars Edvinsson; Thomas Hedner
Histamine-independent modulation of the neuropeptide Y-induced pressor response by alpha-trinositol in the pithed rat.
Pharmacology & toxicology 1994;75(6):371-6.
1994: W Schubert; G Cullberg; B Edgar; Thomas Hedner
Inhibition of 17 beta-estradiol metabolism by grapefruit juice in ovariectomized women.
Maturitas 1994;20(2-3):155-63.
1994: Michael L X Fu; Johan Hoebeke; S Matsui; M Matoba; Y Magnusson; Thomas Hedner; Hans Herlitz; Ake Hjalmarson
Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension.
Clinical immunology and immunopathology 1994;72(1):15-20.
1994: Jan Lötvall; H Lunde; L E Augustinson; Thomas Hedner; N Svedmyr; E Ben-Menachem
Airway effects of direct left-sided cervical vagal stimulation in patients with complex partial seizures.
Epilepsy research 1994;18(2):149-54.
1994: R Björkman; K M Hallman; Jan Hedner; Thomas Hedner; M Henning
Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P.
Pain 1994;57(3):259-64.
1994: Lars Edvinsson; David Erlinge; XY Sun; Thomas Hedner
Neuropeptide Y in sympathetic co-transmission: recent advances in the search for neuropeptide Y antagonists.
Pharmacology & toxicology 1994;74(4-5):193-201.
1994: Ola Samuelsson; Thomas Hedner; G Berglund; B Persson; O K Andersson; L Wilhelmsen
Diabetes mellitus in treated hypertension: incidence, predictive factors and the impact of non-selective beta-blockers and thiazide diuretics during 15 years treatment of middle-aged hypertensive men in the Primary Prevention Trial Göteborg, Sweden.
Journal of human hypertension 1994;8(4):257-63.
1994: Q P Feng; S Carlsson; P Thorén; Thomas Hedner
Characteristics of renal sympathetic nerve activity in experimental congestive heart failure in the rat.
Acta physiologica Scandinavica 1994;150(3):259-66.
1994: Ola Samuelsson; Thomas Hedner; B Persson; O Andersson; G Berglund; L Wilhelmesen
The role of diabetes mellitus and hypertriglyceridaemia as coronary risk factors in treated hypertension: 15 years of follow-up of antihypertensive treatment in middle-aged men in the Primary Prevention Trial in Göteborg, Sweden.
Journal of internal medicine 1994;235(3):217-27.
1994: H Lunde; Thomas Hedner; Ola Samuelsson; Jan Lötvall; L Andrén; L Lindholm; B E Wiholm
Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors.
BMJ (Clinical research ed.) 1994;308(6920):18-21.
1993: Thomas Wallén; Sten Landahl; Thomas Hedner; Jan Hedner; C Hall
Atrial peptides, ANP(1-98) and ANP(99-126) in health and disease in an elderly population.
European heart journal 1993;14(11):1508-13.
1993: X Sun; Lars Edvinsson; Thomas Hedner
Cardiovascular effects of alpha-trinositol in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
Journal of hypertension 1993;11(9):935-43.
1993: Björn Dahlöf; L Hansson; L H Lindholm; B Scherstén; PO Wester; T Ekbom; Thomas Hedner; Ulf de Faire
STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Swedish Trial in Old Patients with Hypertension.
Blood pressure 1993;2(2):136-41.
1993: R Eggertsen; A Andreasson; Thomas Hedner; B E Karlberg; L Hansson
Effect of coffee on ambulatory blood pressure in patients with treated hypertension.
Journal of internal medicine 1993;233(4):351-5.
1993: W Schubert; G Cullberg; Thomas Hedner
Pharmacokinetic evaluation of oral 17 beta-oestradiol and two different fat soluble analogues in ovariectomized women.
European journal of clinical pharmacology 1993;44(6):563-8.
1992: Thomas Hedner; X Sun; I L Junggren; A Pettersson; Lars Edvinsson
Peptides as targets for antihypertensive drug development.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1992;10(7):S121-32.
1992: R L Björkman; Thomas Hedner; K M Hallman; M Henning; Jan Hedner
Localization of the central antinociceptive effects of diclofenac in the rat.
Brain research 1992;590(1-2):66-73.
1992: L Hansson; Thomas Hedner; Björn Dahlöf
Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point.
Blood pressure 1992;1(2):113-9.
1992: XY Sun; Thomas Hedner; Q Feng; Lars Edvinsson
Inhibition of endothelin (ET-1) induced pressor responses by the endothelin (ETA) receptor antagonist FR139317 in the pithed rat.
Blood pressure 1992;1(2):108-12.
1992: E Blychert; B Edgar; D Elmfeldt; Thomas Hedner
Plasma concentration--effect relationships for felodipine: a meta analysis.
Clinical pharmacology and therapeutics 1992;52(1):80-9.
1992: XY Sun; Lars Edvinsson; Thomas Hedner
Effects of d-myo-inositol-1,2,6-trisphosphate on neuropeptide Y-induced potentiation of various vasoconstrictor agents in the rat.
The Journal of pharmacology and experimental therapeutics 1992;261(3):1147-52.
1992: Q P Feng; S Carlsson; P Thorén; Thomas Hedner
Effects of clonidine on renal sympathetic nerve activity, natriuresis and diuresis in chronic congestive heart failure rats.
The Journal of pharmacology and experimental therapeutics 1992;261(3):1129-35.
1992: Thomas Hedner; Ola Samuelsson; H Lunde; L Lindholm; L Andrén; B E Wiholm
Angio-oedema in relation to treatment with angiotensin converting enzyme inhibitors.
BMJ (Clinical research ed.) 1992;304(6832):941-6.
1992: B Persson; Ove K Andersson; M Wysocki; Thomas Hedner; B Karlberg
Calcium antagonism in essential hypertension: effect on renal haemodynamics and microalbuminuria.
Journal of internal medicine 1992;231(3):247-52.
1992: Elinor Ben-Menachem; L I Persson; Thomas Hedner
Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin.
Epilepsy research 1992;11(1):45-9.
1992: Q L Gong; Jan Hedner; R Björkman; Thomas Hedner
Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat.
Pain 1992;48(2):249-55.
1992: XY Sun; Q P Feng; Q L Gong; Lars Edvinsson; Thomas Hedner
Cardiovascular and renal effects of gamma-MSH in spontaneously hypertensive and normotensive Wistar Kyoto rats.
The American journal of physiology 1992;262(1 Pt 2):R77-84.
1992: Thomas Hedner; B Edgar; Lars Edvinsson; Jan Hedner; B Persson; A Pettersson
Yohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers.
European journal of clinical pharmacology 1992;43(6):651-6.
1992: Ola Samuelsson; Thomas Hedner; S Ljungman; Hans Herlitz; B Widgren; K Pennert
A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension.
European journal of clinical pharmacology 1992;43(5):469-75.
1991: Q P Feng; S Carlsson; P Thorén; Thomas Hedner
Clonidine influences renal sympathetic nerve activity and renal function in experimental heart failure.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S58-9.
1991: XY Sun; Q P Feng; Lars Edvinsson; Thomas Hedner
Gamma-melanocyte-stimulating hormones have pressor and natriuretic effects in spontaneously hypertensive and Wistar-Kyoto rats.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S346-7.
1991: XY Sun; Lars Edvinsson; Thomas Hedner
Neuropeptide Y-induced pressor responses in spontaneously hypertensive and Wistar-Kyoto rats antagonized by D-myo-inositol-1,2,6-triphosphate (PP56).
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S344-5.
1991: Thomas Hedner; Ola Samuelsson; L Lindholm; L Andrén; B E Wiholm
Precipitation of angioedema by antihypertensive drugs.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1991;9(6):S360-1.
1991: XY Sun; Carl G H Dahlöf; Lars Edvinsson; Thomas Hedner
D-myo-inositol-1,2,6-trisphosphate is a selective antagonist of neuropeptide Y-induced pressor responses in the pithed rat.
European journal of pharmacology 1991;204(3):281-6.
1991: Z B Chen; Göran Engberg; Thomas Hedner; Jan Hedner
Antagonistic effects of somatostatin and substance P on respiratory regulation in the rat ventrolateral medulla oblongata.
Brain research 1991;556(1):13-21.
1991: B R Widgren; Hans Herlitz; Thomas Hedner; G Berglund; John Wikstrand; O Jonsson; Ove K Andersson
Blunted renal sodium excretion during acute saline loading in normotensive men with positive family histories of hypertension.
American journal of hypertension 1991;4(7 Pt 1):570-8.
1991: H Samuelsson; Thomas Hedner
Pain characterization in cancer patients and the analgetic response to epidural morphine.
Pain 1991;46(1):3-8.
1991: T Thulin; Thomas Hedner; S Gustafsson; S O Olsson
Diltiazem compared with metoprolol as add-on-therapies to diuretics in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group.
Journal of human hypertension 1991;5(2):107-14.
1991: B R Widgren; Thomas Hedner; Jan Hedner; G Berglund; John Wikstrand; Ove K Andersson
Resting and volume-stimulated circulating atrial natriuretic peptide in young normotensive men with positive family histories of hypertension.
Journal of hypertension 1991;9(2):139-46.
1991: Q L Gong; Thomas Hedner; Jan Hedner; R Björkman; G Nordberg
Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide.
European journal of pharmacology 1991;193(1):47-56.
1991: B Andersson; M E Zimmermann; Thomas Hedner; Per Björntorp
Haemodynamic, metabolic and endocrine effects of short-term dexfenfluramine treatment in young, obese women.
European journal of clinical pharmacology 1991;40(3):249-54.
1991: E Blychert; B Edgar; D Elmfeldt; Thomas Hedner
A population study of the pharmacokinetics of felodipine.
British journal of clinical pharmacology 1991;31(1):15-24.
1991: C Dahlöf; Thomas Hedner; T Thulin; S Gustafsson; S O Olsson
Effects of diltiazem and metoprolol on blood pressure, adverse symptoms and general well-being. The Swedish Diltiazem-Metoprolol Multi-Centre Study Group.
European journal of clinical pharmacology 1991;40(5):453-60.
1991: K Gradin; Thomas Hedner; B Persson
Antihypertensive effects of chronic 5-hydroxytryptamine (5-HT2) receptor blockade with irindalone in the spontaneously hypertensive rat.
Journal of neural transmission. General section 1991;83(3):227-33.
1990: Z B Chen; Thomas Hedner; Jan Hedner
Local application of somatostatin in the rat ventrolateral brain medulla induces apnea.
Journal of applied physiology (Bethesda, Md. : 1985) 1990;69(6):2233-8.
1990: Q P Feng; Thomas Hedner; Jan Hedner; A Pettersson
Blunted renal response to atrial natriuretic peptide in congestive heart failure rats is reversed by the alpha 2-adrenergic agonist clonidine.
Journal of cardiovascular pharmacology 1990;16(5):776-82.
1990: K Gradin; S Carlsson; Thomas Hedner; B Persson
Cardiovascular effects of irindalone, a new S2-serotonergic antagonist, in the rat.
Pharmacology & toxicology 1990;67(3):199-204.
1990: Björn Dahlöf; D Gustafsson; Thomas Hedner; Sverker Jern; L Hansson
Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction.
Journal of hypertension 1990;8(9):811-7.
1990: R Björkman; Jan Hedner; Thomas Hedner; M Henning
Central, naloxone-reversible antinociception by diclofenac in the rat.
Naunyn-Schmiedeberg's archives of pharmacology 1990;342(2):171-6.
1990: Z Chen; Jan Hedner; Thomas Hedner
Substance P in the ventrolateral medulla oblongata regulates ventilatory responses.
Journal of applied physiology (Bethesda, Md. : 1985) 1990;68(6):2631-9.
1990: E Blychert; Thomas Hedner; C Dahlöf; D Elmfeldt
Plasma concentration-effect relationships of intravenous and extended-release oral felodipine in hypertensive patients.
Journal of cardiovascular pharmacology 1990;15(3):428-35.
1990: Z B Chen; Jan Hedner; Thomas Hedner
Local effects of substance P on respiratory regulation in the rat medulla oblongata.
Journal of applied physiology (Bethesda, Md. : 1985) 1990;68(2):693-9.
1990: Thomas Hedner; Jan Hedner; A Gelin-Friberg; M L Huang; S Van de Poel; R Woestenborghs; Achiel Van Peer; J Heykants
Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers.
European journal of clinical pharmacology 1990;38(6):629-31.
1990: Thomas Hedner; T Thulin; S Gustafsson; S O Olsson
A comparison of diltiazem and metoprolol in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group.
European journal of clinical pharmacology 1990;39(5):427-33.
1989: Ove K Andersson; B Persson; Thomas Hedner; Mattias Aurell; M Wysocki
Blood pressure control and haemodynamic adaptation with the dihydropyridine calcium antagonist isradipine: a controlled study in middle-aged hypertensive men.
Journal of hypertension 1989;7(6):465-9.
1989: B Persson; Ove K Andersson; M Wysocki; Thomas Hedner; Mattias Aurell
Renal and hemodynamic effects of isradipine in essential hypertension.
The American journal of medicine 1989;86(4A):60-4.
1989: K Gradin; A Pettersson; Thomas Hedner; B Persson
Central sympathoinhibitory effect of ketanserin in the spontaneously hypertensive rat.
Pharmacology & toxicology 1989;64(4):352-5.
1989: Anders Pettersson; Jan Hedner; Thomas Hedner
Renal interaction between sympathetic activity and ANP in rats with chronic ischaemic heart failure.
Acta physiologica Scandinavica 1989;135(4):487-92.
1989: Thomas Hedner; Marianne Hartford; Kenneth Caidahl; Jan Hedner; A C Towle; Susanne Ljungman; John Wikstrand; G Berglund
Atrial natriuretic peptide (ANP) in relation to blood pressure: a study in middle-aged men with normal and elevated blood pressure.
Journal of internal medicine 1989;225(4):229-35.
1989: Anders Pettersson; Jan Hedner; Thomas Hedner
Relationship between renal sympathetic activity and diuretic effects of atrial natriuretic peptide (ANP) in the rat.
Acta physiologica Scandinavica 1989;135(3):323-33.
1989: Jan Hedner; Thomas Hedner; K H Lundell; Garth Bissette; L O'Connor; Charles Nemeroff
Cerebrospinal fluid concentrations of neurotensin and corticotropin-releasing factor in pediatric patients.
Biology of the neonate 1989;55(4-5):260-7.
1988: Jan Hedner; Hasse Ejnell; Johan Sellgren; Thomas Hedner; G Wallin
Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension?
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S529-31.
1988: Anders Pettersson; Sven-Erik Ricksten; Jan Hedner; Thomas Hedner
Differential haemodynamic effects of atrial natriuretic peptide (ANP) in normotensive and spontaneously hypertensive rats.
Acta physiologica Scandinavica 1988;134(2):247-51.
1988: Z Chen; Thomas Hedner; Jan Hedner
Hypoventilation and apnoea induced by the substance P antagonist [D-Pro2,D-Trp7,9]-SP in the ventrolateral rat medulla.
Acta physiologica Scandinavica 1988;134(1):153-4.
1988: Anders Pettersson; Sven-Erik Ricksten; A C Towle; Jan Hedner; Thomas Hedner
Haemodynamics and plasma ANP (atrial natriuretic peptide) after acute blood volume expansion in normotensive and spontaneously hypertensive rats.
Acta physiologica Scandinavica 1988;133(4):513-8.
1988: Thomas Hedner; B Persson
Effects of a new serotonin antagonist, ketanserin, in experimental and clinical hypertension.
American journal of hypertension 1988;1(3 Pt 3):317S-323S.
1988: B Andersson; G Wallin; Thomas Hedner; A C Ahlberg; O K Andersson
Acute effects of short-term fasting on blood pressure, circulating noradrenaline and efferent sympathetic nerve activity.
Acta medica Scandinavica 1988;223(6):485-90.
1988: H Herlitz; B Fagerberg; O Jonsson; Thomas Hedner; O K Andersson; Mattias Aurell
Effects of sodium restriction and energy reduction on erythrocyte sodium transport in obese hypertensive men.
Annals of clinical research 1988;20 Suppl 48():61-5.
1988: Thomas Hedner; L Hansson
A utilitarian or deontological approach toward primary prevention of cardiovascular disease?
Acta medica Scandinavica 1988;224(4):293-302.
1988: Thomas Hedner; B Bergman; U Freyschuss; G Grossmann; B Robertson
Effects of antenatal hydrocortisone on tidal volumes in spontaneously breathing preterm newborn rabbits. Possible mediation by adrenal catecholamines.
Biology of the neonate 1988;54(4):211-7.
1988: Thomas Hedner; Ove K Andersson; K Winther; B Persson
Are there reasons to believe that the antihypertensive effects of serotonin (S2) antagonists are age-related?
Journal of cardiovascular pharmacology 1988;12 Suppl 8():S132-46.
1988: Thomas Hedner; B Persson
Experience with ketanserin and ritanserin in hypertensive patients.
Journal of cardiovascular pharmacology 1988;11 Suppl 1():S44-8.
1988: B Persson; K Gradin; A Pettersson; Thomas Hedner
Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat.
Journal of cardiovascular pharmacology 1988;11 Suppl 1():S22-4.
1987: Jan Hedner; Thomas Hedner
beta-Casomorphins induce apnea and irregular breathing in adult rats and newborn rabbits.
Life sciences 1987;41(20):2303-12.
1987: Thomas Hedner; D Elmfeldt; H Von Schenck; E Sjögren; U Smith
Glucose tolerance in hypertensive patients during treatment with the calcium antagonist, felodipine.
British journal of clinical pharmacology 1987;24(2):145-9.
1987: Thomas Hedner; D Elmfeldt; C Dahlöf; E Sjögren
Comparison of antihypertensive effect and pharmacokinetics of conventional and extended release felodipine tablets in patients with arterial hypertension.
Drugs 1987;34 Suppl 3():125-31.
1987: Thomas Hedner
Clinical evaluation of felodipine in hypertensive patients previously treated with a triple drug regimen.
Drugs 1987;34 Suppl 3():161.
1987: Ove K Andersson; Thomas Hedner; G Granérus
Felodipine in combination with a beta-blocker and a diuretic in chronic treatment of patients with refractory primary hypertension.
Drugs 1987;34 Suppl 3():156-60.
1987: Thomas Hedner; A Pettersson; B Persson
Chronic 5-HT2-receptor blockade by ritanserin does not reduce blood pressure in patients with essential hypertension.
Acta medica Scandinavica 1987;222(4):307-10.
1987: Thomas Hedner; Ove K Andersson; A Pettersson; B Persson
Cardiovascular effects of ketanserin during cold pressure and during isometric and dynamic exercise in hypertensive patients.
Journal of cardiovascular pharmacology 1987;10 Suppl 3():S73-7.
1987: L Hansson; Thomas Hedner
The rationale for ketanserin therapy in hypertension.
Journal of cardiovascular pharmacology 1987;10 Suppl 3():S39-44.
1987: Thomas Hedner; E Sjögren; D Elmfeldt
Antihypertensive effects and pharmacokinetics of felodipine combined with a beta-blocker and a diuretic.
Journal of cardiovascular pharmacology 1987;10 Suppl 1():S177-84.
1986: Thomas Hedner; Ola Samuelsson; E Sjögren; D Elmfeldt
Treatment of essential hypertension with felodipine in combination with a diuretic.
European journal of clinical pharmacology 1986;30(2):133-9.
1986: Ove K Andersson; B Persson; G Granérus; M Wysocki; Mattias Aurell; Thomas Hedner; Jan Hedner
Release of atrial natriuretic peptide (alpha-hANP) and circulating noradrenaline in relation to central and renal hemodynamics and sodium output during acute volume load in hypertensive and normotensive men.
Acta medica Scandinavica. Supplementum 1986;714():133-7.
1985: B Fagerberg; O K Andersson; B Persson; Thomas Hedner; Jan Hedner; A Towle
Fluid homeostasis and haemodynamics during sodium restriction in hypertensive men.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1985;3(3):S327-9.
1985: A Pettersson; S E Ricksten; A Towle; Jan Hedner; Thomas Hedner
Plasma atrial natriuretic peptide and haemodynamics in conscious normotensive and spontaneously hypertensive rats after acute blood volume expansion.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1985;3(3):S311-3.
1985: Ove K Andersson; G Granérus; Thomas Hedner; M Wysocki
Systemic and renal hemodynamic effects of single oral doses of felodipine in patients with refractory hypertension receiving chronic therapy with beta-blockers and diuretics.
Journal of cardiovascular pharmacology 1985;7(3):544-9.
1985: Ove K Andersson; G Granérus; Thomas Hedner
Felodipine. A calcium-inhibiting vasodilator in refractory hypertension.
Drugs 1985;29 Suppl 2():102-8.
1985: A Pettersson; K Gradin; Thomas Hedner; M Henning; B Persson
Chronic serotonergic blockade with ketanserin in the spontaneously hypertensive rat.
Journal of cardiovascular pharmacology 1985;7 Suppl 7():S112-3.